In this video, Professor Dr. Milan Latas explains that comorbidity in anxiety disorders is often under-recognized in routine clinical practice, which can obscure the true clinical picture. He emphasizes the importance of systematically asking about co-occurring substance use, depression, and personality disorders to secure an accurate diagnosis and guide care. With a proper diagnostic work-up, clinicians can plan treatment for both the primary anxiety disorder and any comorbid conditions; without it, multiple concurrent diagnoses—often two or more—can complicate the plan and even undermine outcomes. The talk also outlines how deliberate treatment planning grounded in good practice improves results, and when to choose medication, psychotherapy, or an integrated approach—noting that patients with comorbidities typically benefit from comprehensive, combined treatments. 

Professor Dr. Milan Latas
Belgrade University School of Medicine and Clinic for Psychiatry, Clinical Center of Serbia 

Related content

description Article
An Introduction to Genetics in Anxiety Disorders: Overview and Outlook
20.05.2026 Anxiety Disorders
image Image An overview of methods used within genetic research related to anxiety, including family, twin, linkage, association, GxE, and molecular, cellular and clinical studies.
Overview of approaches used to study the genetics of anxiety disorders
20.05.2026 Anxiety Disorders
image Image graphs showing the impact of anxiety disorders on suicide
The impact of anxiety disorders on suicide

Suicidal ideation is far more common than attempts in people with anxiety or depression, especially with comorbid disorders and severe depression.

08.04.2026 Anxiety Disorders